Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem CellsMyeloid Progenitor CellsBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraHematopoiesisGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingCell DifferentiationHistocompatibility TestingHistocompatibilityMice, Inbred C57BLProtein PrecursorsLeukemia, Myeloid, AcuteCyclophosphamideTransplantation, IsogeneicLeukemia, MyeloidGranulocytesBone Marrow DiseasesKidney TransplantationColony-Forming Units AssayRecurrenceRadiation ChimeraCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGranulocyte Colony-Stimulating FactorBone Marrow ExaminationTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressive AgentsRemission InductionTreatment OutcomeHematologic NeoplasmsGraft RejectionBone RemodelingHepatic Veno-Occlusive DiseaseLeukopoiesisMyeloid CellsBone Marrow NeoplasmsTransplantation ImmunologyCells, CulturedGraft vs Host ReactionStem Cell TransplantationMyelopoiesisImmunosuppressionLymphocyte DepletionAntigens, CD34Leukocyte TransfusionLymphoma, Non-HodgkinAcute DiseaseHeart TransplantationT-LymphocytesFlow CytometryChimeraSevere Combined ImmunodeficiencyMyelodysplastic SyndromesHLA AntigensSurvival AnalysisCell LineageStem CellsRetrospective StudiesLung TransplantationCyclosporineBone DensityHematologic DiseasesActuarial AnalysisCell SeparationLymphocyte TransfusionMice, KnockoutNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineAntigens, CDOrgan TransplantationSpleenPancytopeniaGraft vs Tumor EffectLeukocyte CountFollow-Up StudiesGraft vs Leukemia EffectMice, Inbred BALB CBone ResorptionCytarabineGranulocyte-Macrophage Colony-Stimulating FactorSurvival RateCytomegalovirus InfectionsAntibodies, Monoclonal